All News
Tech Xplore / Setting the standard for more durable concrete
As infrastructure ages, one question shapes the future of cities: How do we know the materials we build with will last?
Medical Xpress / New AI tool improves heart test evaluation
A new AI tool can rapidly evaluate data from echocardiography, an imaging test commonly used to diagnose heart disease, according to new research led by Cedars-Sinai. The study, published in JACC, found the tool could speed ...
Medical Xpress / Slow turning could be an indicator for Parkinson's disease
An international study has found that wearable technology could help detect Parkinson's disease (PD) up to nine years before clinical diagnosis simply by monitoring how people turn when they walk.
Medical Xpress / Examining impact of federal relief program after major health care cyberattack
New research from the University of Minnesota School of Public Health provides the first detailed look at whether funding provided through a federal relief program effectively reached hospitals affected by a ransomware attack ...
Medical Xpress / The world is facing a cancer crisis that's hitting the most vulnerable hardest
When I worked on the latest Global Burden of Disease cancer study, a global project that tracks cancer patterns and deaths across countries, I found myself pausing as the numbers loaded on the screen. Even as a scientist ...
Medical Xpress / Liver cancer prevention, treatment efforts are working
Prevention and treatment advances are reducing the number of new liver cancer patients and narrowing survival gaps among racial groups, a Cedars-Sinai Cancer study published in the journal Clinical Gastroenterology and Hepatology ...
Medical Xpress / TikTok videos mislead on epilepsy care, experts say
Fake clickbait TikTok videos about epilepsy treatments are receiving more views than accurate, evidence-based offerings, a new study says.
Tech Xplore / EU pushes back 2035 combustion-engine ban review to Dec. 16
A highly anticipated review of the EU's 2035 ban on new petrol and diesel car sales has been pushed back to next week, the European Commission said Monday.
Medical Xpress / Aza–ven combination outperforms standard care in AML patients eligible for intensive chemotherapy
In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen of azacitidine and venetoclax compared with conventional induction chemotherapy. The azacitidine–venetoclax ...
Medical Xpress / Adding epcoritamab to standard second-line therapy improves follicular lymphoma outcomes
In a new trial, patients with follicular lymphoma had a significantly higher response to treatment and a nearly 80% reduction in the risk of death or disease progression if they received epcoritamab in addition to the standard ...
Medical Xpress / New findings support a chemo-free approach for treating Ph+ ALL
A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial, which included adult ...
Medical Xpress / IV iron improves survival, increases hemoglobin in patients with iron-deficiency anemia and acute infection
Treatment with intravenous (IV) iron significantly improved survival and increased hemoglobin levels in patients with iron-deficiency anemia who were hospitalized for an acute bacterial infection, according to an analysis ...
